YOLFTbeta
EVE Health Group Limited

EVE Health Group Limited

EVE · AU · Consumer Defensive / Packaged Foods

0.013AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.013
Open0.014
Day Range0.013 – 0.014
52-Week Range0.014 – 0.036
Volume115.00K
Market Cap5.28M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.01
Dividend Yield0.00%
Beta0.45
50-Day Avg0.016
200-Day Avg0.0208

About

EVE Health Group Limited, a life sciences and healthcare company, engages in the development and commercialization of pharmaceutical products in Australia. It operates in two segments, Meluka (Branded Wellness Consumer Products) and Nextract (Pharmaceutical Products and Intellectual Property). Its lead product is the Dyspro, a formulation developed to address dysmenorrhoea and Endometriosis Pain; and Libbo, an oral dissolving film for erectile dysfunction. The company also develops Apixaban to treat anticoagulation. The company was formerly known as EVE Investments Limited. EVE Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOMr. Benedict James Rohr
  • Employees0
  • Headquarters245 Churchill Avenue, Subiaco, WA, Australia, 6008, Australia
  • Websitehttps://www.evehealthgroup.com.au

Leadership

  • Mr. Benedict James RohrChief Executive Officer
  • Dr. Stuart GunzburgCSO & Executive Director
  • Mr. Steven Luke Jackson BEc, C.P.A.CFO & Company Secretary

Financials

Income Statement

Currency: AUD2004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue-32.00K122.00K441.00K318.00K-539.00K7.65M-6.80K2.82K198-13825018.90K1.60M2.31M2.80M2.01M2.33M2.13M1.73M1.15M
Growth (%)--+281.25%+261.48%-27.89%--+1319.48%---58.56%-92.97%-169.70%+281.16%+7461.60%+8353.24%+44.62%+21.20%-28.28%+16.03%-8.45%-18.71%-33.53%
Cost of Revenue----------00-143001.64M2.76M3.51M3.01M1.50M1.26M910.70K1.26M
Gross Profit---------6.80K2.82K-18.28K524518.90K-37.47K873.73K-713.50K-1.00M827.83K876.96K824.03K-106.51K
Gross Margin---------100.00%100.00%-9231.31%-3.62%98.00%100.00%-2.34%37.81%-25.47%-49.98%35.51%41.09%47.50%-9.24%
Operating Expense---------1.09M431.46K397.72K881.00K902.33K1.46M2.11M3.49M3.12M2.88M3.11M2.42M2.25M1.79M
Operating Income-100.89K-165.64K-281.00K-3.12M-3.65M-3.43M-2.64M-2.41M-4.83M-1.09M-428.64K-416.00K-881.00K-902.08K-1.44M-2.14M-2.62M-3.83M-3.88M-2.28M-1.54M-1.43M-1.90M
Operating Margin--517.63%-230.33%-706.80%-1148.74%--489.98%-31.53%--15965.89%-15208.58%-210101.01%638405.80%-360832.80%-7638.60%-134.17%-113.20%-136.88%-193.33%-97.91%-72.35%-82.33%-164.81%
EBITDA-158.35K-165.64K-278.00K-3.24M-3.95M-4.49M-6.55M21.24M-2.19M-15.47M-331.21K-415.00K-1.01M-900.06K-236.00K-2.39M-2.72M-2.79M-4.53M-2.18M-1.51M-1.43M-1.77M
EBITDA Margin--517.63%-227.87%-735.37%-1243.08%--1214.66%277.61%--227418.41%-11751.77%-209595.96%730434.78%-360024.00%-1248.41%-149.62%-117.65%-99.59%-225.44%-93.67%-70.62%-82.18%-153.28%
Net Income-92.72K-133.63K-246.00K-2.65M-3.00M-3.60M-3.39M21.22M-5.20M-17.38M-386.68K-7.37M-1.10M-1.39M-1.88M-2.64M-2.40M-3.63M-5.37M-4.04M-1.90M-1.58M-1.89M
Net Income Margin--417.58%-201.64%-602.04%-943.71%--628.39%277.36%--255571.89%-13719.83%-3721212.12%800000.00%-554941.20%-9944.99%-165.14%-103.85%-129.63%-267.40%-173.49%-89.08%-91.08%-163.97%
R&D----------------------209.51K
R&D as % of Total Revenue----------------------18.17%
Interest Expense8.55K0000000000000086.53K7.33K48.35K14.11K-34.92K27.10K3.14K
Interest Expense % of Total Revenue-0.00%0.00%0.00%0.00%-0.00%0.00%-0.00%0.00%0.00%0.00%0.00%0.00%5.41%0.32%1.73%0.70%-1.64%1.56%0.27%

Balance Sheet

Currency: AUD2004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets395.33K2.50M6.30M19.42M26.83M23.33M26.38M26.68M23.68M8.26M8.19M2.77M1.92M3.07M7.46M8.78M14.11M11.92M8.07M4.13M2.52M4.12M4.28M
Total Liabilities143.99K274.98K317.49K641.12K1.19M399.39K1.23M1.04M644.97K79.23K84.42K129.08K171.29K293.55K76.80K2.93M1.12M1.74M1.14M1.01M1.30M572.45K330.02K
Total Equity251.35K2.22M5.98M15.29M16.45M14.91M12.22M25.64M23.04M8.18M8.11M2.64M1.75M2.78M7.38M5.85M12.99M10.19M6.93M3.12M1.22M3.55M3.95M
Cash41.79K1.74M1.52M11.31M8.62M1.66M6.68M1.23M1.41M224.52K366.86K138.39K332.48K260.29K3.91M340.26K5.14M3.16M1.10M192.48K106.17K903.42K1.24M
Total Debt100.00K108.55K-------------1.30M584.31K1.01M492.40K4.28K74.85K91.28K-
Net Debt58.21K-1.63M-1.52M-11.31M-8.62M-1.66M-6.68M-1.23M-1.41M-224.52K-366.86K-138.39K-332.48K-260.29K-3.91M959.60K-4.55M-2.15M-610.03K-188.20K-31.31K-812.14K-1.24M

Cash Flow

Currency: AUD2004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-55.71K-146.87K-212.78K-1.37M-2.52M-2.91M-2.26M-5.00M-1.58M-779.82K-157.19K-240.46K-645.76K-558.99K-808.76K-1.07M-3.16M-2.24M-3.77M-1.65M-1.11M-1.62M-1.74M
Investing Cash Flow--310.00K-1.22M-3.05M-7.15M-4.01M-3.01M-2.48M241.69K-507.54K-121.98K10.30K-1.72M-1.73M-975.20K-3.18M-557.11K-263.38K-26.05K498.46K874.27K2.13M-1.90K
Financing Cash Flow7.39K2.15M1.23M14.16M7.07M-55.64K10.36M2.02M1.51M-5.13K428.59K2.42K2.56M2.21M5.44M676.40K8.51M529.43K1.74M240.69K146.37K279.09K2.08M
Capital Expenditure0035.60K258.64K495.84K282.92K32.97K5.55M2.59M507.54K151.41K52.00K32.95K63.42K63.42K63.42K322.61K263.38K26.05K1.63K431.90K
Free Cash Flow-55.71K-146.87K-248.38K-1.63M-3.01M-3.19M-2.29M-10.56M-4.17M-1.29M-308.61K-292.46K-678.71K-558.99K-808.76K-1.13M-3.48M-2.51M-3.80M-1.65M-1.11M-1.62M-1.74M
Dividends Paid---------------891.81K7.88M610.43K1.71M277.78K---
FCF to OCF100.00%100.00%116.73%118.88%119.69%109.74%101.46%211.02%264.25%165.08%196.32%121.62%105.10%100.00%100.00%105.92%110.22%111.74%100.69%100.10%100.00%100.00%100.11%
Dividend Paid to FCF----------------78.60%-226.67%-24.34%-45.06%-16.83%---

Earnings

Report DateMar 1, 2016Sep 1, 2016Feb 28, 2017Sep 1, 2017Feb 26, 2018Aug 31, 2018Feb 28, 2019Sep 1, 2019Feb 24, 2020Aug 31, 2020Feb 23, 2021Aug 31, 2021Feb 28, 2022Aug 31, 2022Feb 27, 2023Feb 28, 2025Aug 29, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.01-0.01
Surprise-----------------
Timing-------------After-hoursAfter-hours--

Key Statistics & Ratios

Market Cap5.28M
Enterprise Value4.75M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales4.58
Price / Book1.43
EPS-0.01
Book Value0.011
Revenue (TTM)1.15M
Gross Profit (TTM)527.50K
EBITDA-1.77M
Profit Margin-163.97%
Operating Margin-201.63%
Return on Equity-50.43%
Return on Assets-28.27%
Shares Outstanding352.33M
Shares Float128.93M
Beta0.45
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jun 2, 20251:40